Benzinga - If history is any guide, there may be trouble ahead for shares of Alnylam Pharmaceuticals (NASDAQ:ALNY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
What To Know: Many traders use moving average crossover systems to make their decisions.
When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term average price, it means the trend is lower.
Why It's Important: The 50-day and the 200-day simple moving averages are commonly used.
The death cross occurs when the 50-day moves below the 200-day. This could mean the long-term trend is changing.
That just happened with Alnylam Pharmaceuticals, which is trading around $205.06 at publication time.
Remember: Seasoned investors don't blindly trade Death Crosses.
Instead, they use it as a signal to start looking for short positions based on other factors, like price levels and company fundamentals & events.
For seasoned investors, this is just a sign that it might be time to start considering possible short positions.
With that in mind, take a look at Alnylam Pharmaceuticals's past and upcoming earnings expectations:
EPS Estimate | -1.90 | -1.78 | -1.62 | -1.84 |
EPS Actual | -1.39 | -1.58 | -2.03 | -1.49 |
Revenue Estimate | 313.13M | 293.03M | 255.88M | 243.02M |
Revenue Actual | 335.04M | 264.31M | 224.82M | 213.26M |
Also consider this overview of Alnylam Pharmaceuticals analyst ratings:
Do you use the Death Cross signal in your trading or investing? Share this article with a friend if you found it helpful!
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.